Universal-Beteiligungs- und Servicegesellschaft
STOK icon

Universal-Beteiligungs- und Servicegesellschaft’s Stoke Therapeutics STOK Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Buy
17,067
+861
+5% +$27.6K ﹤0.01% 1750
2026
Q1 		$528K Buy
+16,206
New +$531K ﹤0.01% 1701

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's STOK Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Stoke Therapeutics (STOK) stake by 5.3% in Q2 2026, buying an estimated $27.6K and bringing the position to 17,067 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in STOK in Q1 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 17,067 shares of Stoke Therapeutics worth $558K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 861 Stoke Therapeutics shares in Q2 2026, an estimated $27.6K.
  • Stoke Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1750 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Stoke Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.